Stay updated on Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page has updated the lead researcher from Hope Rugo, MD to Laura Huppert, MD, and the study dates have been revised to reflect new timelines, with the latest date now set for May 2, 2025.
    Difference
    2%
    Check dated 2025-05-07T00:31:48.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The webpage has been updated to include new collaborators and investigators associated with a breast cancer study, while significant details about the study's design and patient criteria have been removed.
    Difference
    48%
    Check dated 2025-04-29T20:28:45.000Z thumbnail image
  3. Check
    23 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 6, 2025.
    Difference
    0.3%
    Check dated 2025-04-08T09:09:54.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to v2.14.3, replacing the previous date of January 6, 2025, and revision v2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T05:13:51.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.9%
    Check dated 2025-03-03T10:51:42.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T01:49:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial page.